Video

Tina Felfeli, MD Research Scholar Honoree Program 2020 Presentation

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
Related Content
Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary endpoint
July 21st 2025

Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary endpoint

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

New law broadens prescribing and procedure rights for Minnesota optometrists
July 21st 2025

New law broadens prescribing and procedure rights for Minnesota optometrists

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470
July 20th 2025

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470

Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United States
July 19th 2025

Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United States

© 2025 MJH Life Sciences

All rights reserved.